Nifty
:
18633.85
Sensex
:
62969.13
35.20 (0.19%)
122.75 (0.20%)
Nifty
Sensex
:
:
18633.85
62969.13
35.20 (0.19%)
122.75 (0.20%)

Wanbury Ltd.

Pharmaceuticals & Drugs

Rating :
42/99

BSE: 524212 | NSE: WANBURY

NSE BSE
44.75
29-May-2023
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 47.10
  • 47.10
  • 44.75
  • 47.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  16351
  •  7.41
  •  74.30
  •  33.30

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 147.31
  • 2.07
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 189.02
  • N/A
  • -4.09

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 39.84%
  • 14.75%
  • 37.83%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 7.58%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.08
  • 6.61
  • 11.63

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.11
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 8.12

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 1.47

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -1.28
  • -1.88
  • -2.94

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.18
  • 17.78
  • 14.62

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Net Sales
125.78
124.84
0.75%
123.95
124.09
-0.11%
116.94
127.86
-8.54%
134.39
120.45
11.57%
Expenses
119.32
116.00
2.86%
118.36
116.98
1.18%
119.98
121.31
-1.10%
121.58
122.22
-0.52%
EBITDA
6.46
8.84
-26.92%
5.60
7.11
-21.24%
-3.04
6.55
-
12.81
-1.77
-
EBIDTM
5.13%
7.08%
4.52%
5.73%
-2.60%
5.12%
9.53%
-1.47%
Other Income
0.26
0.26
0.00%
0.78
0.31
151.61%
1.94
0.31
525.81%
0.64
1.21
-47.11%
Interest
6.63
5.64
17.55%
3.94
5.16
-23.64%
3.31
5.02
-34.06%
4.79
5.79
-17.27%
Depreciation
3.13
3.03
3.30%
3.15
2.78
13.31%
3.03
2.64
14.77%
3.00
2.59
15.83%
PBT
-3.04
0.43
-
-0.71
-0.53
-
-7.45
-0.81
-
82.03
-8.93
-
Tax
0.23
0.06
283.33%
0.18
0.06
200.00%
-0.21
0.06
-
-0.51
0.03
-
PAT
-3.28
0.37
-
-0.89
-0.58
-
-7.25
-0.86
-
82.55
-8.96
-
PATM
-2.61%
0.30%
-0.72%
-0.47%
-6.20%
-0.67%
61.42%
-7.43%
EPS
-1.00
0.11
-
-0.27
-0.18
-
-2.22
-0.26
-
25.27
-3.58
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Sep 14
Mar 13
Net Sales
501.06
511.19
392.52
367.45
391.37
371.10
433.81
423.26
249.92
661.86
459.11
Net Sales Growth
0.77%
30.23%
6.82%
-6.11%
5.46%
-14.46%
2.49%
69.36%
-62.24%
44.16%
 
Cost Of Goods Sold
305.30
300.28
221.33
175.74
196.20
174.09
196.97
182.40
119.30
304.08
249.64
Gross Profit
195.76
210.90
171.19
191.72
195.17
197.01
236.83
240.87
130.62
357.78
209.46
GP Margin
39.07%
41.26%
43.61%
52.18%
49.87%
53.09%
54.59%
56.91%
52.26%
54.06%
45.62%
Total Expenditure
479.24
479.45
376.85
389.07
378.00
439.03
415.28
390.89
228.50
637.65
491.22
Power & Fuel Cost
-
18.41
17.13
15.38
14.46
15.26
18.74
18.51
10.05
28.07
17.98
% Of Sales
-
3.60%
4.36%
4.19%
3.69%
4.11%
4.32%
4.37%
4.02%
4.24%
3.92%
Employee Cost
-
74.81
64.15
67.48
75.72
87.10
87.59
85.41
39.57
111.53
80.90
% Of Sales
-
14.63%
16.34%
18.36%
19.35%
23.47%
20.19%
20.18%
15.83%
16.85%
17.62%
Manufacturing Exp.
-
12.66
9.98
13.77
7.98
10.21
15.04
12.34
2.98
14.62
8.23
% Of Sales
-
2.48%
2.54%
3.75%
2.04%
2.75%
3.47%
2.92%
1.19%
2.21%
1.79%
General & Admin Exp.
-
20.58
23.63
28.56
30.47
29.66
34.37
29.80
25.49
47.41
35.66
% Of Sales
-
4.03%
6.02%
7.77%
7.79%
7.99%
7.92%
7.04%
10.20%
7.16%
7.77%
Selling & Distn. Exp.
-
31.31
16.86
19.63
27.41
29.49
42.43
34.19
15.15
62.46
37.43
% Of Sales
-
6.12%
4.30%
5.34%
7.00%
7.95%
9.78%
8.08%
6.06%
9.44%
8.15%
Miscellaneous Exp.
-
21.40
23.78
68.51
25.77
93.22
20.14
28.26
15.96
69.48
37.43
% Of Sales
-
4.19%
6.06%
18.64%
6.58%
25.12%
4.64%
6.68%
6.39%
10.50%
13.37%
EBITDA
21.83
31.74
15.67
-21.62
13.37
-67.93
18.53
32.37
21.42
24.21
-32.11
EBITDA Margin
4.36%
6.21%
3.99%
-5.88%
3.42%
-18.31%
4.27%
7.65%
8.57%
3.66%
-6.99%
Other Income
3.62
5.09
4.75
46.20
11.50
76.70
89.69
1.40
6.48
11.29
4.84
Interest
18.67
20.61
23.07
32.87
39.88
30.86
35.51
31.87
18.62
48.26
37.23
Depreciation
12.31
11.45
9.75
9.68
9.97
10.30
10.32
9.05
4.80
23.37
22.59
PBT
70.83
4.76
-12.41
-17.97
-24.98
-32.39
62.40
-7.15
4.48
-36.15
-87.09
Tax
-0.31
-0.35
0.20
0.21
-0.14
-0.38
0.38
0.00
1.27
2.86
0.14
Tax Rate
-0.44%
-0.43%
-1.61%
0.32%
0.56%
1.17%
0.61%
0.00%
28.35%
-2.29%
-0.16%
PAT
71.13
81.47
-12.61
64.46
-24.85
-32.01
62.01
-7.15
3.20
-127.71
-87.23
PAT before Minority Interest
71.13
81.47
-12.61
64.46
-24.85
-32.01
62.01
-7.15
3.20
-127.71
-87.23
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
14.20%
15.94%
-3.21%
17.54%
-6.35%
-8.63%
14.29%
-1.69%
1.28%
-19.30%
-19.00%
PAT Growth
809.17%
-
-
-
-
-
-
-
-
-
 
EPS
21.75
24.91
-3.86
19.71
-7.60
-9.79
18.96
-2.19
0.98
-39.06
-26.68

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Sep 14
Mar 13
Shareholder's Funds
-23.42
-156.24
-143.45
-209.28
-184.68
-153.28
-188.77
-193.94
-191.71
-47.96
Share Capital
32.67
25.02
25.00
23.72
23.72
23.22
19.97
19.97
19.97
17.38
Total Reserves
-57.01
-181.60
-168.66
-233.23
-208.66
-176.50
-220.96
-213.91
-211.68
-65.34
Non-Current Liabilities
10.56
84.43
107.74
130.36
105.79
159.92
251.37
298.18
311.67
346.79
Secured Loans
0.00
71.99
99.54
123.03
99.01
153.73
230.92
270.48
279.35
310.20
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.13
Long Term Provisions
12.07
13.75
11.56
10.69
10.14
9.55
8.76
7.48
6.75
7.16
Current Liabilities
359.77
355.35
311.04
361.60
348.25
401.91
298.61
264.85
259.43
447.41
Trade Payables
191.61
133.77
121.87
112.24
83.13
140.11
86.11
99.15
93.69
78.35
Other Current Liabilities
150.30
200.56
160.75
160.69
178.59
194.50
118.92
85.47
89.17
283.97
Short Term Borrowings
13.21
16.42
24.92
85.21
82.67
63.19
90.60
77.85
74.18
73.81
Short Term Provisions
4.66
4.60
3.50
3.47
3.85
4.12
2.97
2.37
2.39
11.28
Total Liabilities
346.91
283.54
275.33
282.68
269.36
408.55
387.87
395.75
406.05
772.90
Net Block
167.11
167.38
163.90
172.36
178.33
186.34
180.27
164.05
173.67
423.31
Gross Block
226.95
215.98
203.10
202.03
198.61
196.65
325.72
305.65
309.76
593.06
Accumulated Depreciation
59.84
48.59
39.20
29.66
20.28
10.32
145.46
141.60
136.09
169.75
Non Current Assets
173.71
182.28
181.69
184.53
191.66
216.83
223.94
214.65
219.39
582.95
Capital Work in Progress
2.35
11.01
13.89
8.97
10.05
9.58
14.42
18.52
12.96
25.05
Non Current Investment
0.01
0.01
0.01
0.02
0.02
0.03
0.01
0.01
0.01
0.54
Long Term Loans & Adv.
3.80
3.40
3.80
3.11
2.84
20.46
28.98
31.08
32.02
134.03
Other Non Current Assets
0.44
0.46
0.10
0.07
0.41
0.43
0.26
0.99
0.73
0.01
Current Assets
171.24
97.53
93.64
98.15
77.70
191.73
163.93
181.11
186.67
189.96
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
49.73
24.85
12.26
19.33
13.07
34.23
34.61
33.77
35.16
42.84
Sundry Debtors
62.80
34.47
50.79
44.41
29.46
84.66
74.94
98.52
103.19
84.38
Cash & Bank
25.31
11.70
16.70
5.25
6.21
9.37
7.22
12.03
6.69
16.90
Other Current Assets
33.40
23.09
9.42
26.47
28.96
63.47
47.15
36.78
41.63
45.83
Short Term Loans & Adv.
2.16
3.42
4.47
2.69
6.27
37.16
29.41
16.51
21.52
36.15
Net Current Assets
-188.53
-257.82
-217.41
-263.44
-270.55
-210.19
-134.68
-83.74
-72.76
-257.45
Total Assets
344.95
279.81
275.33
282.68
269.36
408.56
387.87
395.76
406.06
772.91

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Sep 14
Mar 13
Cash From Operating Activity
40.52
16.68
44.13
29.73
32.49
43.39
43.05
40.17
68.17
87.44
PBT
81.13
-12.41
64.67
-24.98
-32.39
62.40
-7.15
4.48
-124.85
-87.09
Adjustment
-43.68
33.22
-41.41
42.90
39.71
-37.29
47.85
22.65
191.19
93.60
Changes in Working Capital
3.24
-3.00
20.90
11.88
26.05
18.33
2.36
13.13
2.07
80.96
Cash after chg. in Working capital
40.69
17.81
44.16
29.80
33.37
43.43
43.07
40.25
68.40
87.47
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.16
-1.13
-0.03
-0.06
-0.89
-0.04
-0.01
-0.08
-0.23
-0.04
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
0.59
8.04
63.66
-3.07
-1.39
-13.06
-19.63
-5.33
-6.20
-20.53
Net Fixed Assets
-2.31
-10.00
-5.99
-2.34
-2.43
133.91
-15.98
-1.45
-7.18
-15.15
Net Investments
0.00
0.00
0.01
0.00
0.01
-0.02
0.00
0.00
106.06
-0.27
Others
2.90
18.04
69.64
-0.73
1.03
-146.95
-3.65
-3.88
-105.08
-5.11
Cash from Financing Activity
-28.58
-17.39
-107.87
-26.78
-33.26
-26.93
-28.07
-29.54
-70.68
-64.16
Net Cash Inflow / Outflow
12.52
7.34
-0.08
-0.13
-2.16
3.39
-4.65
5.29
-8.70
2.74
Opening Cash & Equivalents
10.00
2.66
2.74
2.87
5.03
1.63
6.28
0.99
9.69
6.95
Closing Cash & Equivalent
22.53
10.00
2.66
2.74
2.87
5.03
1.63
6.28
0.99
9.69

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Sep 14
Mar 13
Book Value (Rs.)
-7.55
-62.60
-57.48
-88.32
-77.97
-66.01
-112.21
-109.34
-108.90
-53.40
ROA
25.85%
-4.51%
23.10%
-9.00%
-9.44%
15.57%
-1.82%
0.80%
-21.66%
-11.03%
ROE
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
ROCE
428.79%
87.61%
444.45%
50.26%
-2.00%
70.48%
15.27%
13.85%
-31.06%
-12.92%
Fixed Asset Turnover
2.32
1.88
1.83
2.08
2.00
1.70
1.37
0.83
1.50
0.80
Receivable days
34.50
39.45
46.85
32.42
52.61
65.66
72.98
144.54
50.69
77.31
Inventory Days
26.45
17.17
15.54
14.22
21.80
28.32
28.77
49.39
21.08
39.71
Payable days
197.75
210.79
243.11
106.12
125.89
110.93
100.14
182.52
57.27
72.19
Cash Conversion Cycle
-136.80
-154.17
-180.72
-59.49
-51.47
-16.96
1.60
11.41
14.50
44.83
Total Debt/Equity
-2.72
-1.02
-1.14
-1.11
-1.19
-1.76
-1.67
-1.74
-1.79
-4.47
Interest Cover
4.94
0.46
2.97
0.37
-0.05
2.76
0.78
1.24
-1.59
-1.34

Annual Reports:

FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.